par
Barbara Kram, Editor | April 18, 2006
-Medical expertise and diagnosis:
-Standardized treatment protocols by publishing Guidelines for the Management of Hemophilia, the first international guidelines for hemophilia care
-National hemophilia organizations:
Ad Statistics
Times Displayed: 134286
Times Visited: 7699 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
-Motivated hemophilia communities by encouraging countries to form national organizations and recruit newly- or already-diagnosed people with hemophilia
About Hemophilia
People with hemophilia do not produce adequate amounts of factor VIII, which is necessary for blood to effectively clot. If untreated, patients with severe hemophilia A have a greatly reduced life expectancy. According to the World Health Organization, more than 400,000 people in the world have hemophilia, corresponding to a prevalence of 15 to 20 in every 100,000 males
born worldwide.
About Baxter
Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE:BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Back to HCB News
